ORIC — Oric Pharmaceuticals Inc

Stock analysis, trade plans, and proprietary indicators by Trend Edge.

Trend Edge Setup Score

Trend Edge rates ORIC Bullish with a Setup Score of 0, net conviction 37, actionability 0. How the Setup Score works →

Total Setup Score0
Directional BiasBullish
Net Conviction37
Actionability0 (extended)

Key signals behind this score

About Oric Pharmaceuticals Inc

ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of therapies to counter the resistance mechanisms in cancers in the United States. Its clinical stage product candidates include enozertinib formerly known as ORIC-114, a brain penetrant orally bioavailable irreversible inhibitor, currently under Phase 1b study, that selectively target epidermal growth factor receptor (EGFR) exon 20 an… Read full Trend Edge analysis →

Trend Edge Proprietary Indicators

Key Metrics

Current Price$13.46
Market Cap$1.44B
Float88.7M
Shares Outstanding103.7M
vs. Analyst Target+53.5% to analyst PT
Dividend RateNone
Analyst Target Price$20.67 (12 analysts)

Financial History

Annual Revenue & Earnings History

YearRevenueNet IncomeGross ProfitEBITDA
2020 N/A -$73.7M -$970,000 -$48.4M
2021 N/A -$77.7M -$897,000 -$78.0M
2022 N/A -$89.1M -$966,000 -$85.8M
2023 N/A -$101M -$1.0M -$99.7M
2024 N/A -$128M -$1.1M -$127M
2025 N/A -$129M -$1.2M -$128M

Recent Quarterly Revenue & Net Income

QuarterRevenueNet Income
Sep 2025 N/A -$32.6M
Dec 2025 N/A -$30.5M
Mar 2026 N/A -$35.8M
Jun 2026 N/A -$41.5M

Ownership & Float

Insider Ownership1.6%
Institutional Ownership122.7%
Short Float24.6%
% of All Funds Holding2.06%
Number of Funds Holding181

Current Moving Averages

Trend Edge tracks near-term, medium-term, cyclical, and secular moving averages across weekly and monthly timeframes to identify trend structure at every horizon.

TimeframeSMAValueTrend Context
Weekly10-Week SMA$12.10Near-term / short-term trend
Weekly40-Week SMA$10.57Medium-term trend
Weekly80-Week SMA$9.91Cyclical trend (business cycle)
Weekly200-Week SMA$8.80Secular trend (multi-year)
Monthly10-Month SMA$11.01Near-term monthly trend
Monthly20-Month SMA$10.18Medium-term monthly trend
Monthly40-Month SMA$9.63Secular monthly trend

Volume Shelves — Support & Resistance

Trend Edge identifies volume shelves: price zones where historically elevated trading volume creates structural support or resistance. A volume shelf forms when a disproportionate share of cumulative volume was transacted at a specific price level, making it a high-conviction anchor for future price reactions.

Price LevelTypeVolume RatioAge
$8.50 support 1.27x 1 months ago
$8.30 support 1.37x 6 months ago
$5.70 support 2.09x 14 months ago

Historical Earnings Reactions (26 events)

TimeframeAvg ReturnMedianWin RateBestWorst
Gap 1.16% 0.80% 61.54% 9.17% -2.87%
1 Day 3.77% 2.02% 73.08% 27.08% -11.58%
1 Week 6.60% 5.95% 57.69% 43.85% -18.00%
2 Weeks 7.76% 5.04% 61.54% 50.00% -25.42%
1 Month 7.94% 3.91% 56.00% 63.51% -39.15%

Next earnings: October 22, 2026 (58 days away)

Seasonality & Day-of-Week Patterns

Monthly Seasonality

Insufficient historical data for monthly seasonality analysis (requires 7+ years of data).

Day-of-Week Tendencies

DayAvg ReturnWin RateSamples
Monday 0.28% 45.8% 297
Tuesday 0.27% 45.0% 329
Wednesday -0.37% 46.8% 327
Thursday 0.09% 48.0% 319
Friday 0.31% 47.0% 317

Top Institutional Holders

Institutional holder breakdown coming soon.

Total institutional ownership: 122.7%

Insider Transactions — Smart Summary

Total insider ownership: 1.6%

12-Month Insider Activity Summary

Total Filings11
Net Value-$3.9M
Net Shares Change-179,082
% of Float-0.2%
C-Suite Filings8
Clusters Detected1

Key Insiders

NameTitleNet ValueFilingsActivity
Chacko Jacob PRESIDENT AND CEO -$3.2M 4 N/A
Piscitelli Dominic Chief Financial Officer -$573,093.888 2 N/A
Heyman Richard A. -$235,892.82 3 N/A
Multani Pratik S Chief Medical Officer -$97,128.56 1 N/A

Transaction Clusters

PeriodFilingsInsidersNet ValueSeniority
2025-12-17 – 2025-12-17 3 3 -$496,624.488 3 C-suite

Significant Filings

DateInsiderTitleNet ValuePrice After
2025-10-02 Chacko Jacob PRESIDENT AND CEO -$1.1M Transaction at $12.04, now +11.8%
2025-09-24 Chacko Jacob PRESIDENT AND CEO -$1.3M Transaction at $10.80, now +24.6%
2025-12-17 Piscitelli Dominic Chief Financial Officer -$97,127.488 Transaction at $9.06, now +48.6%
2025-12-17 Multani Pratik S Chief Medical Officer -$97,128.56 Transaction at $9.06, now +48.6%
2026-07-28 Heyman Richard A. -$151,862 Transaction at $8.55, now +57.5%
2025-12-17 Chacko Jacob PRESIDENT AND CEO -$302,368.44 Transaction at $9.06, now +48.6%

View full insider transaction history on Trend Edge →

AI Consult Analysis

Trend Edge's AI Consult feature delivers a comprehensive, multi-layer trade plan for Oric Pharmaceuticals Inc (ORIC) powered by Claude Opus — Anthropic's most capable AI model. The analysis covers five layers: technical analysis (near-term, medium-term, cyclical, and secular trend, momentum, volume shelf support and resistance, breakout and breakdown signals), qualitative analysis (business model, competitive moat, sector dynamics), insider sentiment (buy and sell signals from executive and director transactions), share stats analysis (institutional accumulation, fund positioning, short float squeeze potential), and fundamental analysis (valuation, revenue growth, profit margin, earnings quality).

AI Consult synthesizes all five layers into a single bullish or bearish thesis with explicit entry, exit, stop loss, and take profit levels — giving you a complete, AI-powered trade plan with defined risk/reward. Whether you are building a long position, initiating a short, or looking for a reversal setup, AI Consult identifies the highest-probability signal from the current trend.

Get the full AI Consult analysis for ORIC on Trend Edge →